These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

128 related articles for article (PubMed ID: 3149933)

  • 21. Effects of misoprostol on histamine-related gastric secretion in man.
    Wilson DE; Wilson PC
    J Assoc Acad Minor Phys; 1989; 1(1):16-8. PubMed ID: 2520847
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Effect of enprostil on amphibian gastroduodenal and human gastric bicarbonate secretion.
    Shorrock CJ; Gibbons LC; Rees WD
    Dig Dis Sci; 1989 Jul; 34(7):1016-20. PubMed ID: 2501074
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Enprostil. A preliminary review of its pharmacodynamic and pharmacokinetic properties, and therapeutic efficacy in the treatment of peptic ulcer disease.
    Goa KL; Monk JP
    Drugs; 1987 Nov; 34(5):539-59. PubMed ID: 3121276
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Effect of enprostil on basal and meal-stimulated gastric acid and pepsin secretion, serum gastrin and gastric emptying in healthy persons.
    Berstad K; Massey H; Berstad A
    Aliment Pharmacol Ther; 1988 Feb; 2(1):65-72. PubMed ID: 2979235
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Protection against aspirin-induced antral and duodenal damage with enprostil. A double-blind endoscopic study.
    Cohen MM; McCready DR; Clark L; Sevelius H
    Gastroenterology; 1985 Jan; 88(1 Pt 2):382-6. PubMed ID: 3917264
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Reduction by enprostil of aspirin-induced blood loss from human gastric mucosa.
    Hawkey CJ; Simpson G; Somerville KW
    Am J Med; 1986 Aug; 81(2A):50-3. PubMed ID: 3092655
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Effect of two-week treatment with enprostil (35 micrograms twice a day) on 24-hour serum gastrin levels.
    Florent C; Cogoni C; Joubert M; Desaint B
    Dig Dis Sci; 1990 Nov; 35(11):1352-7. PubMed ID: 2121423
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Effect of enprostil, a synthetic prostaglandin E2 on 24 hour intragastric acidity, nocturnal acid and pepsin secretion.
    Deakin M; Ramage J; Paul A; Gray SP; Billings J; Williams JG
    Gut; 1986 Sep; 27(9):1054-7. PubMed ID: 3093317
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Effect of oral and intravenous 16,16-dimethyl prostaglandin E2 in duodenal ulcer and Zollinger-Ellison syndrome patients.
    Ippoliti AF; Isenberg JI; Hagie L
    Gastroenterology; 1981 Jan; 80(1):55-9. PubMed ID: 7450412
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Inhibition of nocturnal gastric secretion in normal human volunteers by misoprostol: a synthetic prostaglandin E1 methyl ester analog.
    Akdamar K; Agrawal N; Ertan A
    Am J Gastroenterol; 1982 Dec; 77(12):902-4. PubMed ID: 6816064
    [TBL] [Abstract][Full Text] [Related]  

  • 31. [The treatment of patients with duodenal peptic ulcer with a synthetic prostaglandin E2 analog (enprostil)].
    Loginov AS; Zverkov IV; Kondashova ZD; Sokolova GN; Minushkin ON
    Ter Arkh; 1992; 64(8):77-9. PubMed ID: 1440404
    [No Abstract]   [Full Text] [Related]  

  • 32. Inhibition of hydrogen-potassium-stimulated adenosine triphosphatase: effects on acid secretion, plasma gastrin, and the gastric mucosa.
    McGuigan JE
    Gastroenterology; 1989 Oct; 97(4):1045-8. PubMed ID: 2550308
    [No Abstract]   [Full Text] [Related]  

  • 33. The effect of enprostil on food stimulated gastrin secretion in the rhesus monkey.
    Fisher PE; Wong A; Garay GL; Rosenkranz RP
    Proc West Pharmacol Soc; 1988; 31():37-40. PubMed ID: 3145504
    [No Abstract]   [Full Text] [Related]  

  • 34. Protective effect of enprostil against aspirin-induced gastroduodenal mucosal injury in man. Comparison with cimetidine and sucralfate.
    Stiel D; Ellard KT; Hills LJ; Brooks PM
    Am J Med; 1986 Aug; 81(2A):54-8. PubMed ID: 3092656
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Central gastric antisecretory action of prostaglandin E2: the involvement of the pituitary gland.
    Puurunen J
    J Pharmacol Exp Ther; 1984 Dec; 231(3):713-6. PubMed ID: 6594506
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Gastrointestinal and uterine effects of enprostil.
    Wong AG; Turke ML; Perry MR; Blissard DD; Faurot G; Hsu S; Ku P; Smith WL
    Proc West Pharmacol Soc; 1989; 32():41-7. PubMed ID: 2506550
    [No Abstract]   [Full Text] [Related]  

  • 37. Inhibition of gastric secretion by a new H2-antagonist, YM-11170 in healthy subjects.
    Miwa M; Tani N; Miwa T
    Int J Clin Pharmacol Ther Toxicol; 1984 Apr; 22(4):214-7. PubMed ID: 6325352
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Local effects of 16, 16-dimethyl prostaglandin E2 on gastric blood flow and acid secretion.
    Cheung LY; Lowry SF
    Surgery; 1981 Aug; 90(2):291-8. PubMed ID: 7256541
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Protective effect of low dose of enprostil against gastric blood loss induced by aspirin in man.
    Thiefin G; Fierfort E; Duchateau A; Garbe E; Joubert M; Zeitoun P
    Scand J Gastroenterol; 1989 Sep; 24(7):827-32. PubMed ID: 2508213
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Prolonged influence of a meal on the effect of ranitidine.
    Frislid K; Berstad A
    Scand J Gastroenterol; 1984 May; 19(3):429-32. PubMed ID: 6330872
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.